About Axenis
Axenis is a company based in Paris (France) founded in 2010 was acquired by GenOway in September 2018. Axenis operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Nagi Bioscience, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Commission
& 2 more
-
Employee Count
Not available
-
Acquired by
GenOway
(Sep 04, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Axenis
Investors in Axenis
Axenis has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, GenOway and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Institution of the European Union responsible for upholding the EU treaties
|
Locked | Locked | Locked | |
|
Provider of transgenic rodent models and customized cell lines for preclinical development
|
Locked | Locked | Locked |
Investor details for Axenis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Axenis
Investment portfolio details for Axenis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Axenis
Detailed financials for Axenis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axenis Comparisons
Peer comparison for Axenis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Axenis
Axenis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Nagi Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Developer of a organism on a chip based technology
|
|
| Locked | Locked | Locked |
Humanized models and drug screening technologies are developed for research.
|
Detailed competitors of Axenis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axenis
Complete news archive for Axenis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axenis
Axenis was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Axenis is headquartered in Paris, France.
Axenis was founded in 2010 in Paris, France, within the biotechnology sector. Immunocompromised mice, lacking T-cells, B-cells, and NK cells through Rag2-- and IL-2R-- modifications, are grafted with human blood cells to create the BRGS HIS model. This humanized immune system is applied in studies of immunology, inflammation, infectious diseases, vaccine and drug screening, oncology, stem cell transplantation, gene therapy, and personalized medicine.
Axenis's top competitors include Biocytogen, Applied StemCell and GenOway.
Axenis has 3 investors. Key investors include European Commission, GenOway, and EIC Fund.